Inject near the injury site
After hospitalizations, members must receive a call within three days so the care manager can further explain and clarify the members diagnosis and care instructions
KPV reinforces these effects by suppressing pro-inflammatory cytokines and protecting epithelial and mucosal barriers from immune-mediated damage
BPC-157 has demonstrated no significant toxicity across numerous rodent studies even at high doses (Sikiric et al.), with no reported hepatotoxicity, no cardiovascular signal, and no reported dependence
Some common side effects that have been reported in the existing research include: Mild injection site reactions (e.g., redness, swelling, or pain) Nausea Occasional headaches It is important to recognize that individual responses to DSIP may vary, and some people may experience side effects not listed here